WINNIPEG, Aug. 15, 2013 /PRNewswire/ - IMRIS Inc. (NASDAQ: IMRS; TSX: IM)
("IMRIS" or the "Company") today announced the appointment of R.
Stephen Armstrong to the Company's Board of Directors effective August
Mr. Armstrong has been Executive Vice President and CFO of Patterson
Companies, Inc., since 1999. Patterson is a publicly traded $3.6
billion distributor of supplies, equipment and services to dental,
companion-animal veterinary and therapy professionals. Starting his
career at Ernst and Young LLP in 1973, he became an audit assurance
partner in his 26-year tenure at the firm, primarily serving
publicly-traded national and multinational clients. He is also a Board
member of Delphax Technologies, Inc. and is chair of its Audit
"Steve brings combined global medical products and financial insights to
the IMRIS board of directors," said David Graves, IMRIS Chairman of the
Board. "His broad accounting and industry experience will make an
impact on the board in our continued management and growth."
Mr. Armstrong's background includes extensive experience with Securities
and Exchange Commission registration and reporting requirements,
inventory accounting techniques, acquisition due diligence and
reporting, corporate income tax, and stock compensation programs. A
Minnesota native, Mr. Armstrong has served on the Board of Trustees of
St. John's University in Collegeville, MN, for the past seven years
where he chairs the Finance Committee and sits on the Executive
Committee. He is also a member of the Board of Directors of the
"I look forward to working closely with the IMRIS board and management
team," Mr. Armstrong said. "The innovative IMRIS technology has become
firmly established in the intraoperative MRI market and, now with the
approval of VISIUS® iCT and other products in development, the company is poised for
continued growth in the image guided therapy space."
IMRIS (NASDAQ: IMRS; TSX: IM) is a global leader in providing image
guided therapy solutions through its VISIUS Surgical Theatre - a
revolutionary, multifunctional surgical environment that provides
unmatched intraoperative vision to clinicians to assist in decision
making and enhance precision in treatment. The multi-room suites
incorporate diagnostic quality high-field MR, CT and angio modalities
accessed effortlessly in the operating room setting. VISIUS Surgical
Theatres serve the neurosurgical, spinal, cardiovascular and
cerebrovascular markets and have been selected by 54 leading medical
institutions around the world.
SOURCE IMRIS Inc.